Spinal Cord Injury-related Neuropathic Pain

• FDA approval · 2025-08-15
  FDA Approved: PREGABALIN — Supplemental Application (Indoco Remedies Limited)

  FDA approved a supplemental application for pregabalin from Indoco Remedies Limited, resulting in approval of a generic pregabalin product.

• FDA approval · 2022-03-08
  FDA Approved: PREGABALIN — Original Application (Eskayef Pharmaceuticals Limited)

  FDA approved Eskayef Pharmaceuticals Limited's original application for generic pregabalin (ANDA212988).

• FDA approval · 2020-03-20
  FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)

  FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.

• FDA approval · 2019-07-19
  FDA Approved: PREGABALIN — Original Application (Amneal Pharmaceuticals NY LLC)

  The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for pregabalin, a generic version of Lyrica, for use in the United States. Th…

• CLINICAL_TRIALS trial_result · 2015-01-13
  Clinical Trial Update: Validation Study of Neuropathic Pain

  A completed validation study of neuropathic pain conditions, including spinal cord injury-related neuropathic pain, diabetic peripheral neur…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2011-06-20
  FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc.